Navigation Links
Neurocrine Biosciences Announces the Appointment of George J. Morrow to its Board of Directors
Date:9/30/2015

SAN DIEGO, Sept. 30, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has appointed George J. Morrow to its Board of Directors. Mr. Morrow has over three decades of global pharmaceutical commercial operations leadership experience with Amgen, Glaxo Wellcome, and Merck. He was most recently the Executive Vice President, Global Commercial Operations at Amgen.

"We are excited to welcome George Morrow to the Board of Directors," said William H. Rastetter, Chairman of the Board of Neurocrine Biosciences. "His extensive commercial background and the knowledge and expertise he has gained from leading global pharmaceutical companies will be an invaluable resource as Neurocrine continues its evolution into a commercial organization." 

Mr. Morrow served as Executive Vice President, Global Commercial Operations at Amgen Inc., a global biotechnology company, from 2003 until his retirement in 2011. He joined Amgen in 2001 as Executive Vice President, Worldwide Sales and Marketing. His responsibilities included oversight of all commercial functions for Amgen's broad spectrum of products in more than 50 countries worldwide, and the introduction of multiple new products into global markets. From 1992 to 2001, Mr. Morrow held executive management and commercial positions within several subsidiaries of Glaxo Wellcome, including Group Vice President for Commercial Operations (U.S.), Managing Director (U.K.), and most recently as President and Chief Executive Officer of Glaxo Wellcome, Inc. (U.S.).

Mr. Morrow currently serves on the board of directors of Otonomy, Inc., a biotechnology company, Vical, Inc., a biotechnology company and Align Technology, Inc., a global medical device company. He has previously served on the boards of Glaxo Wellcome, Inc., Human Genome Sciences, Inc., Safeway, Inc., National Commerce Bank, the John Hopkins School of Public Health, and the Duke University Fuqua School of Business. Mr. Morrow holds a B.S. in chemistry from Southampton College, Long Island University, an M.S. in biochemistry from Bryn Mawr College and an M.B.A. from Duke University.

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders.  The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and NBI-98854, a vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders.  Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company. 

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

 


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences to Present at the Morgan Stanley Global Healthcare Conference
2. Neurocrine Biosciences to Present at the Baird 2015 Healthcare Conference
3. Neurocrine Announces Completion of Enrollment into Kinect 3 Tardive Dyskinesia Study
4. Neurocrine Biosciences Reports Second Quarter 2015 Results
5. Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2015 Results
6. Neurocrine Biosciences Provides Update on NBI-77860 Program for Congenital Adrenal Hyperplasia
7. Neurocrine Biosciences to Host Analyst and Investor Day in New York City on May 21, 2015
8. Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
9. Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs
10. Neurocrine Biosciences to Present at the Deutsche Bank 40th Annual Health Care Conference
11. Neurocrine Biosciences Reports First Quarter 2015 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2019)... ... 08, 2019 , ... A new study from researchers at the UConn Rudd ... overwhelmingly engage with fast food, unhealthy snacks, candy and soft drinks filled with sugar. ... get stuck inside with family members visiting from out of town. But a ...
(Date:12/6/2019)... ... December 06, 2019 , ... Food and nutrition ... information and ideas about working toward sustainable nutrition security nationwide, increasing accessibility to ... we develop a healthy and sustainable food system,” said Carol May, CEO of ...
(Date:12/5/2019)... SAN FRANCISCO (PRWEB) , ... December 05, 2019 ... ... senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces key issues to ... 11-12, 2020 at the Four Seasons Hotel in San Francisco. ...
Breaking Medicine Technology:
(Date:12/9/2019)... ... ... OCLI, a Spectrum Vision Partners (SVP) managed practice, has announced the addition ... practice with experience spanning decades. As part of OCLI, Drs. Cary Silverman, Nicholas Xanthos ... 46 Eagle Rock Ave, East Hanover, NJ 07936. , Over the past ...
(Date:12/8/2019)... ... December 08, 2019 , ... Intelligent.com, ... the Top 52 Best Homeland Security Degree Programs for 2020. The comprehensive research ... the nation. Each program is evaluated based on curriculum quality, graduation rate, reputation, ...
(Date:12/6/2019)... ... , ... Allegheny Health Network (AHN) has named Kymberly Gyure, MD, Chair of ... in May 2018, previously served as AHN’s Vice Chair of Pathology and Laboratory Medicine, ... is also part of the pathology faculty at Drexel University College of Medicine. ...
(Date:12/6/2019)... Calif. (PRWEB) , ... December 06, 2019 , ... Dr. ... Sciences program, recently published research on the health benefits of coconut oil in ... Oil Intake and Its Effects on the Cardiometabolic Profile: A Structured Literature Review,” led ...
(Date:12/5/2019)... GILBERT, Ariz. (PRWEB) , ... December 05, 2019 ... ... International , with milestones ranging from launching exceptional products that help people embrace, ... around the world. , “We’ve never been more committed to our mission of ...
Breaking Medicine News(10 mins):